CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Benefits of Outsourcing Regulatory Compliance Services for Chemical Formulations

Benefits of Outsourcing Regulatory...

Key Regulatory Compliance Challenges Facing Life Science Organizations

Key Regulatory Compliance Challenges...

Advarra Offers Cloud-Based Secure Document Exchange To Boost Startup

Advarra Offers Cloud-Based Secure...

Criterion Edge Named Company Of The Year By Life Sciences Review

Criterion Edge Named Company Of The...

Life Sciences Must Prioritize Business Validation

Life Sciences Must Prioritize...

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to...

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a...

Is 2022 the Developmental Phase of Life Sciences?

Is 2022 the Developmental Phase of...

Benefits of Outsourcing Regulatory Compliance Services for Chemical Formulations

Benefits of Outsourcing Regulatory...

Key Regulatory Compliance Challenges Facing Life Science Organizations

Key Regulatory Compliance Challenges...

Advarra Offers Cloud-Based Secure Document Exchange To Boost Startup

Advarra Offers Cloud-Based Secure...

Criterion Edge Named Company Of The Year By Life Sciences Review

Criterion Edge Named Company Of The...

Life Sciences Must Prioritize Business Validation

Life Sciences Must Prioritize...

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to...

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a...

Is 2022 the Developmental Phase of Life Sciences?

Is 2022 the Developmental Phase of...

Life Sciences Industry Moving toward More Agile Regulatory Operations

Life Sciences Review | Wednesday, November 24, 2021
Tweet

Fremont, CA In slightly than a year, two Covid-19 vaccines will be produced, tested, and licenced for usage, along with a variety of therapies, diagnostics, and other medical technology. Industry players, health authorities, and partners have had to adjust to working at a fast pace that appeared unimaginable before. In light of this new normal, the industry's attitude toward automation and cloud technology is swiftly shifting from nice-to-have to must-have, in order to support regulatory and safety compliance while also delivering better health outcomes.


The accelerated push to bring reliable Covid-19 therapies to market has genuinely been a global endeavor, including life sciences businesses and regulatory organizations from all around the world. The entire industry has witnessed firsthand the importance of regulatory compliance agility in order to improve the chances of the speedy, global supply of Covid-19 medicines and vaccines.


In the face of rigorous delivery deadlines imposed by government efforts, agility has proven to be crucial. Whether or not regulations tighten or loosen following the pandemic, life sciences companies will benefit from automation and supporting technological advancements in artificial intelligence, machine learning, and natural language processing to keep up with rapidly changing regulatory standards on a country or regional level. Companies will need to embrace integrative technologies and processes that reduce the need for manual input in order to manage their time and expenses while preserving the momentum created by the pandemic's circumstances.


Furthermore, the capacity to use AI techniques to collect, analyze, and assess patient reactions to drugs would aid vaccination therapy development and evolution. Continuing Covid-related surveillance and signal detection activities, for example, will yield insights that medication makers can subsequently combine with data acquired from other vaccination surveillance programs, such as those undertaken around seasonal influenza. Because of AI-assisted analysis and the reduced possibility of human mistakes throughout the research process, this opens the door to speed the creation of a single medication that can target different infections.


See Also : Agile Software Solution Companies


Weekly Brief

loading
Top 10 Regulatory Services Companies - 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/life-sciences-industry-moving-toward-more-agile-regulatory-operations-nwid-638.html